https://www.selleckchem.com/pr....oducts/adenosine-dis
90; 95%CI 0.82-0.98) in stable patients, with a number needed to treat (NNT) of 59, but no significant changes in FEV , mortality, hospitalizations or quality of life were identified. In stable patients, IA use increased antimicrobial resistance (RR 2.10, 95%CI 1.35-3.27) at the end of therapy, with a number needed to treat of 6. IA therapy achieved a statistically significant eradication of P. aeruginosa from sputum, with a 10% reduction of exacerbations in stable patients. This effect has to be balanced with si
Like
Comment
Share
